HCW Biologics HCWB
NASDAQ HCWB
$0.77 -0.04 (-4.94%)
At close: Nov 13, 2026 · 4:00 PM EST

HCW Biologics (HCWB) Return on Sales [ROS] (2020 - 2026)

Updated

HCW Biologics (HCWB) posted Return on Sales [ROS] of -2335.57% for Q2 2026, up 50551.10 percentage points from -52886.67% a year earlier but down 2385.03 percentage points from the prior quarter.

Analysis

HCW Biologics (HCWB) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at HCW Biologics was -114.33%, up 1357.96 percentage points year-over-year; for FY2025, it came in at -24270.74%, down 23123.14 percentage points from FY2024.

  • Annual Return on Sales [ROS] has declined for three consecutive years, with a five-year change of -24128.67 percentage points (FY2020 to FY2025).
  • In prior years, HCW Biologics' Return on Sales [ROS] was -1147.60% in FY2024 (-242.64 pp), -904.96% in FY2023 (-680.65 pp) and -224.32% in FY2022.
  • Quarterly Return on Sales [ROS] has run from a low of -52886.67% in Q2 2025 to a high of 49.45% in Q1 2026 over five years.
  • On a year-over-year basis, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of -4422.64 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q1 2022, with a gain of 809371.98 percentage points; the weakest was Q2 2025, with a drop of 50440.86 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 49.45% (Q1 2026), -16519.15% (Q4 2025) and -21095.26% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 24.35%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 36.01%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 30.74%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 29.12%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 35.79%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 41.71%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 32.98%
10 HCW Biologics 1.02 Mn -4.00 Mn -93,887.00 -2,335.57%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,335.57%
Mar 31, 2026 49.45%
Dec 31, 2025 -16,519.15%
Sep 30, 2025 -21,095.26%
Jun 30, 2025 -52,886.67%
Mar 31, 2025 -38,811.49%
Dec 31, 2024 -797.23%
Sep 30, 2024 -864.06%
Jun 30, 2024 -2,445.81%
Mar 31, 2024 -665.09%
Dec 31, 2023 -813.31%
Sep 30, 2023 -595.23%
Jun 30, 2023 -724.22%
Mar 31, 2023 -12,798.92%
Dec 31, 2022 -422.45%
Sep 30, 2022 -222.20%
Jun 30, 2022 -773.36%
Mar 31, 2022 -60.33%
Mar 31, 2021 -809,432.31%
Jun 30, 2020 -182,654.86%
API Access

HCW Biologics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=HCWB&period=max&api_key=YOUR_API_KEY